GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Investments And Advances

Pharmosa Biopharm (ROCO:6875) Investments And Advances : NT$0.0 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm Investments And Advances?

Pharmosa Biopharm's Investments And Advances for the quarter that ended in Mar. 2025 was NT$0.0 Mil.


Pharmosa Biopharm Investments And Advances Historical Data

The historical data trend for Pharmosa Biopharm's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm Investments And Advances Chart

Pharmosa Biopharm Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial - - - - -

Pharmosa Biopharm Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pharmosa Biopharm Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Pharmosa Biopharm Business Description

Traded in Other Exchanges
N/A
Address
No. 508, Sec. 7, Zhongxiao E. Road, 11F / 11F-1, Nangang District, Taipei, TWN
Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology. Geographically, the company generates almost all of its revenue from the USA, and a small portion from Taiwan.

Pharmosa Biopharm Headlines

No Headlines